These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9347126)

  • 21. Interactions between environmental stimulation and antipsychotic drug effects on forebrain c-fos activation.
    Murphy CA; Feldon J
    Neuroscience; 2001; 104(3):717-30. PubMed ID: 11440804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
    Ashby DM; Lapish CC; Phillips AG
    Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myoclonus inducing and seizure modifying effect of cysteamine on cortical and amygdaloid kindled rats.
    Takazawa A; Bilkey DK
    Brain Res; 1988 Nov; 473(1):99-106. PubMed ID: 3145096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia.
    Levin ED; Christopher NC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):223-9. PubMed ID: 16356617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats.
    Betz A; Ishiwari K; Wisniecki A; Huyn N; Salamone JD
    Psychopharmacology (Berl); 2005 May; 179(2):383-92. PubMed ID: 15619122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D
    Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.
    Tang AH; Franklin SR; Himes CS; Smith MW; Tenbrink RE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):440-7. PubMed ID: 9103528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
    Ritter LM; Meador-Woodruff JH
    Biol Psychiatry; 1997 Aug; 42(3):155-64. PubMed ID: 9232207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
    McCullumsmith RE; Stincic TL; Agrawal SM; Meador-Woodruff JH
    Eur J Pharmacol; 2003 Sep; 477(2):101-12. PubMed ID: 14519413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.
    Tremblay PO; Gervais J; Rouillard C
    Eur J Neurosci; 1998 Nov; 10(11):3546-55. PubMed ID: 9824467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
    Cohen BM; Cherkerzian S; Ma J; Ye N; Wager C; Lange N
    Psychopharmacology (Berl); 2003 Jun; 167(4):403-10. PubMed ID: 12709776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated exposure to trimethylolpropane phosphate induces central nervous system sensitization and facilitates electrical kindling.
    Lin J; Cassell J; Ritchie GD; Rossi J; Nordholm AF
    Physiol Behav; 1998 Aug; 65(1):51-8. PubMed ID: 9811364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala.
    Morelli M; Pinna A
    Ann N Y Acad Sci; 1999 Jun; 877():703-6. PubMed ID: 10415688
    [No Abstract]   [Full Text] [Related]  

  • 35. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
    Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
    Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
    Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits.
    Nagaraja RY; Grecksch G; Reymann KG; Schroeder H; Becker A
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):26-34. PubMed ID: 15241581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration.
    Marchese G; Sanna A; Casu G; Casti P; Spada GP; Ruiu S; Pani L
    Eur J Pharmacol; 2008 Nov; 598(1-3):16-20. PubMed ID: 18789920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.